These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 17280595

  • 1. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C.
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [Abstract] [Full Text] [Related]

  • 2. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 3. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 4. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M.
    Neuropsychobiology; 2007 Jan; 55(1):28-35. PubMed ID: 17556850
    [Abstract] [Full Text] [Related]

  • 5. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 7. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 8. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M.
    Psychoneuroendocrinology; 2009 Feb; 34(2):238-248. PubMed ID: 18926641
    [Abstract] [Full Text] [Related]

  • 9. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M, Bschor T, Bauer M, Lucka C, Lewitzka U, Ising M, Uhr M, Mueller-Oerlinghausen B, Baethge C.
    Neuropsychobiology; 2009 Jul 01; 60(1):23-30. PubMed ID: 19684420
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 01; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C, Baghai T, Zwanzger P, Ella R, Eser D, Padberg F, Möller HJ, Rupprecht R.
    Psychopharmacology (Berl); 2003 Mar 01; 166(3):271-5. PubMed ID: 12552362
    [Abstract] [Full Text] [Related]

  • 13. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
    Nothdurfter C, Schmotz C, Sarubin N, Baghai TC, Laenger A, Lieb M, Bondy B, Rupprecht R, Schüle C.
    J Psychiatr Res; 2014 May 01; 52():15-20. PubMed ID: 24513501
    [Abstract] [Full Text] [Related]

  • 14. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 01; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 15. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.
    Psychopharmacology (Berl); 2005 Oct 01; 181(4):751-60. PubMed ID: 15988572
    [Abstract] [Full Text] [Related]

  • 16. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
    Hundt W, Zimmermann U, Pöttig M, Spring K, Holsboer F.
    Alcohol Clin Exp Res; 2001 May 01; 25(5):687-91. PubMed ID: 11371718
    [Abstract] [Full Text] [Related]

  • 17. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
    Wilson ME, Fisher J, Brown J.
    Physiol Behav; 2005 Mar 16; 84(3):449-58. PubMed ID: 15763583
    [Abstract] [Full Text] [Related]

  • 18. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr 16; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 19. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Apr 16; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 20. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G.
    Neuro Endocrinol Lett; 2009 Mar 16; 30(1):11-6. PubMed ID: 19300389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.